PD-1 mRNA LNP Vaccine for Advanced Primary Hepatocellular Carcinoma.

计划入组 9 人 · 首次发布于 2025 年 7 月 8 日

Novel mRNA-LNP-Based Intratumoral Immunotherapy in Patients With Advanced Malignant Solid Tumors

计划入组 60 人 · 首次发布于 2026 年 5 月 14 日

A Clinical Study on the Treatment of Wilson Disease With ATP7B mRNA/LNP (DSL101)

计划入组 18 人 · 首次发布于 2025 年 11 月 21 日

mRNA encoding anti-HIV-1 antibody VRC01 (Acuitas Therapeutics)

ZIKV prM-E mRNA-LNP

JCXH-221

Moderna, Inc.

United States

BioNTech SE

Germany

Eterna Therapeutics

United States

mRNA-LNP Therapy with mTOR Inhibition Reprograms Allergic Responses in Preclinical Model

Gilead Builds mRNA-LNP and ADC Capabilities to Advance Oncology and Virology Pipelines

ST Pharm Secures First Japanese Patent for mRNA-LNP Platform Technology STP1244